These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8643208)

  • 21. Chronic renal disease: new therapies to delay kidney replacement.
    Michael B; Burke JF
    Geriatrics; 1994 Aug; 49(8):33-8. PubMed ID: 8039727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protecting the kidney in hypertension.
    Weinberg MS; Cottiero RA; Yoburn DC
    R I Med; 1993 May; 76(5):225-8. PubMed ID: 8518496
    [No Abstract]   [Full Text] [Related]  

  • 23. ACE inhibition and renal protection.
    Ritz E
    Clin Physiol Biochem; 1992; 9(3):94-7. PubMed ID: 1302163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
    Rockx MA; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ACE inhibitors and calcium channel blockers on the development of glomerular sclerosis in models of renal damage.
    Raij L
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():23-7. PubMed ID: 8643203
    [No Abstract]   [Full Text] [Related]  

  • 26. To prevent progression: ACE inhibitors, calcium antagonists or both?
    Stefanski A; Amann K; Ritz E
    Nephrol Dial Transplant; 1995; 10(2):151-3. PubMed ID: 7753444
    [No Abstract]   [Full Text] [Related]  

  • 27. ACE inhibitors and protection against pneumonia in elderly patients with stroke.
    Arai T; Sekizawa K; Ohrui T; Fujiwara H; Yoshimi N; Matsuoka H; Sasaki H
    Neurology; 2005 Feb; 64(3):573-4. PubMed ID: 15699404
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood pressure, proteinuria and nephropathy in Fabry disease.
    Jain G; Warnock DG
    Nephron Clin Pract; 2011; 118(1):c43-8. PubMed ID: 21071972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of renin-angiotensin to calcium channel blockade in renal disease.
    Tikkanen I; Johnston CI
    Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Kidney and hypertension--evidence based medicine].
    Nakao N; Senou H; Kasuga H; Toriyama T; Kawahara H
    Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1639-45. PubMed ID: 15384696
    [No Abstract]   [Full Text] [Related]  

  • 32. [The influence of antihypertensive treatment on progression of chronic nepropathy].
    Petersen LJ; Ladefoged SD; Jensen HA
    Ugeskr Laeger; 1997 Jul; 159(31):4745-51. PubMed ID: 9265325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertension--special reference to kidney diseases].
    Hayashi M
    Nihon Jinzo Gakkai Shi; 2002; 44(5):432-8. PubMed ID: 12216475
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of prolonged angiotensin-converting enzyme inhibition on excretory kidney function and proteinuria in renal allograft recipients with chronic progressive transplant failure.
    Barnas U; Schmidt A; Haas M; Oberbauer R; Mayer G
    Nephrol Dial Transplant; 1996 Sep; 11(9):1822-4. PubMed ID: 8918629
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical use of evidence-based medicine: searching.
    Spier BJ; Feldstein DA
    WMJ; 2006 Jul; 105(5):9-11. PubMed ID: 16933405
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation.
    Kanno Y; Okada H; Yamaji Y; Nakazato Y; Suzuki H
    QJM; 2005 Mar; 98(3):199-203. PubMed ID: 15728401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension and progression of renal disease.
    Maschio G; Oldrizzi L; Marcantoni C; Rugiu C
    J Nephrol; 2000; 13(3):225-7. PubMed ID: 10928300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of angiotensin II and of angiotensin converting enzyme inhibition in chronic renal failure.
    Ledingham JG
    Kidney Int Suppl; 1987 May; 20():S112-6. PubMed ID: 3037159
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diabetes mellitus and hypertension: calcium antagonists or ACE inhibitors?].
    Jungmann E
    Dtsch Med Wochenschr; 1991 May; 116(22):859-62. PubMed ID: 2036945
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiotensin converting enzyme inhibitors and calcium antagonists in the progression of renal insufficiency.
    Zucchelli P; Gaggi R; Zuccalà A
    Contrib Nephrol; 1992; 98():116-24. PubMed ID: 1493723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.